- In September 2023, Thermo Fisher Scientific introduced an advanced line of real-time PCR instruments, offering enhanced speed and high-throughput performance. Designed for both clinical diagnostics and research, the systems feature improved sensitivity, faster thermal cycling, and intuitive software, aiming to streamline workflows in laboratories handling large sample volumes.
- In January 2024, Bio-Rad Laboratories unveiled a new multiplex PCR system focused on improving diagnostic accuracy for infectious diseases. This system enables simultaneous detection of multiple pathogens in a single run, reducing turnaround time and reagent use. The innovation supports labs facing high testing demands and contributes to efficient disease surveillance
- In March 2024, Qiagen launched a digital PCR system tailored for precision oncology and rare mutation detection. The platform offers high sensitivity and quantification capabilities, catering to growing demand for personalized medicine. Its compact design and automated workflows are ideal for clinical labs and translational research centers.
- In February 2024, Agilent Technologies announced a new AI-powered software tool for analyzing PCR data, designed to improve result accuracy and reduce manual interpretation. The tool integrates with Agilent’s existing PCR platforms, enabling real-time analytics and predictive modeling. This innovation enhances efficiency in clinical diagnostics and life sciences research environments.
